New anti-peptic ulcer drug, Ilaprazole on phase III clinical study.

Published: 2005-04-22 06:56:00

Updated: 2005-04-22 06:56:00

Il Yang announced that the new anti-peptic ulcer drug, Ilaprazole that was designated as one of the national strategic study projects, was successfully completed with its phase II clinical study in 5 overseas countries including Australia and Singapore for the past 3 years, and now a global phase...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK